ALHASSAN SUBOH: Open Payments
NPI 1205575180 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,620 in 77 payments from 18 companies in 2025. Trend: 2023 $131 · 2024 $818 · 2025 $1,620
Food & beverage: $1,589Education: $31
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $388 |
| Corcept Therapeutics | 9 | $187 |
| Sequel Med Tech, LLC | 9 | $185 |
| Lilly USA, LLC | 8 | $157 |
| Insulet Corporation | 5 | $129 |
| Ascendis Pharma Endocrinology Inc | 6 | $119 |
| ABBVIE INC. | 7 | $102 |
| Abbott Laboratories | 3 | $69 |
| Chiesi USA, Inc. | 2 | $49 |
| Verity Pharmaceuticals Inc. | 2 | $47 |
Products named: Ozempic, Korlym, TWIIST, MOUNJARO, Omnipod, Yorvipath, Wegovy, Rybelsus.
Industry payments across TN — which companies pay providers there.
